Lighting the path to pain relief with optogenetics™
Revolutionizing pain treatment through optogenetic gene therapies—an
alternative to opioids and spinal cord stimulators.
Our Quest to Solve the American Pain Epidemic
Enter Optogenetic Neuromodulation
What is This Groundbreaking Treatment?
The therapy works by turning pain-blocking neurons in the spine into photoreceptors – like in your eyes – so they can be activated with a simple LED light. The light sensitive proteins are delivered to the neurons using functionalized gold nanorods and low power laser light with a promotor so they are only activated in those neurons that can block pain.
Traditional care is electrical stimulation, which affects all neurons – those that block pain and those that transmit pain; Opsin’s therapy is specific to only work on those neurons that block pain. The potentially transformative therapy would be an alternative to electrical spinal cord stimulation, offering relief to millions of people suffering from chronic pain with limited or no recourse to other treatment options.
This technology will be utilized to advance the study and development of a non-viral, gene delivery system for optogenetic neuromodulation of the spine, providing a groundbreaking solution for severe chronic pain management without the need for opioids.
How Our Optogenetic neuromodulation works
Discover the Future of Biotechnology with Opsin Biotherapeutics, Inc.
Our therapies are in development and have not been approved by any regulatory agency and are not available for human use. Information provided is for educational purposes only.
Copyright © 2025 Opsin Biotherapeutics, Inc. - All Rights Reserved.